We are accepting proposals for symposia from BAP members for the #BAP2027 Summer Meeting which will be held in Newcastle. Deadline 6th March. For more information and to submit a proposal go to

REGISTER NOW for #BAP2026 Summer Meeting in Birmingham, 19th - 22nd July. For more information and to register go to

It was a real privilege to be invited to present on treatment-resistance in anxiety disorders at the Psychiatry Masterclass 2025 at the Conrad Dubai. Many thanks to the organising and scientific committees for inviting me! It was great to be there with such excellent speakers!

Our new Insights article out now in European Neuropsychopharmacology We argue that poor control conditions in digital therapeutics trials risk misleading efficacy claims. Let’s raise the bar for DTx trial design. 🔗 authors.elsevier.com/a/1l-8p,L21E... @ecnp.eu #DTx #MentalHealth #ClinicalTrials

It was great to present on placebo and nocebo effects in depressive and anxiety disorders in an educational update session at the ECNP Congress. Many thanks to the educational committee for inviting me! @ecnp.eu

🎥 Two new #SFB289 #webinars are uploaded on our YouTube channel! 🎥 In September 2025, @nathanhuneke.bsky.social presented his work on placebo effects in psychiatric disorders: youtu.be/Z1pyhXSV5RE

Great to collaborate on this with @hvansteenbergen.bsky.social! We found evidence that endogenous opioids mediate attentional broadening after receiving rewards.

Really enjoyed the opportunity to present at the SFB289 webinar!

Great to be part of this

Our new study published in TheLancetPsych! We found that pramipexole augmentation substantially reduced depressive symptoms in patients with treatment-resistant depression over 48 weeks of treatment. This is an important advance in how we treat depression! 1/6 www.thelancet.com/journals/lan...

Timely article!

Our thoughts on missing data, statistics and placebo effects in psychiatric trials. Thanks Samuele Cortese and Marco Solmi! jamanetwork.com/journals/jam...

Very important initiative!

Our new review in JAMA Psychiatry: "Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric Disorders" jamanetwork.com/journals/jam... Thanks to co-first author Guil Fusetto-Veronesi; and to Samuele Cortese, David Baldwin, Matt Garner 🧵👇

Our new review in JAMA Psychiatry: "Expectancy Effects, Failure of Blinding Integrity, and Placebo Response in Trials of Treatments for Psychiatric Disorders" jamanetwork.com/journals/jam... Thanks to co-first author Guil Fusetto-Veronesi; and to Samuele Cortese, David Baldwin, Matt Garner 🧵👇

🧠 Help Us Understand Pain Perception in FND! 🧠 Looking for volunteers with & without #FND for a study in London @kingsioppn.bsky.social. Single lab visit testing pain perception with electrical stimulation. Interested? Please message me: [email protected] ✉️ Thanks for sharing!

Why academia is sleepwalking into self-destruction. My editorial @brain1878.bsky.social If you agree with the sentiments please repost. It's important for all our sakes to stop the madness academic.oup.com/brain/articl...

#Pubmed problems being reported Please say if it’s working for you, your country and search engine (perhaps retweet for larger sample size 🤷‍♂️ fine for me, UK & Safari

Pleased to be able to share our meta-analysis exploring placebo and nocebo response in gambling disorder, out now in Acta Neuropsychiatrica. This is the first meta-analysis of placebo response in RCTs for gambling disorder. https://buff.ly/3V8dnk3

New starter pack: Mental Health Professionals For facts/expertise, but not individual clinical advice! Just getting started... will add more as time goes by... bsky.app/starter-pack...

Huge congratulations to all the nominees and winners at last night’s #VCAwards2024 🏆✨ Held at St Mary’s Stadium, it was an inspiring evening recognising the dedication and talent across our University. #WeAreUoS

Is there a way to search for starter packs?

Trying bluesky again. Which feeds should I follow?

Very pleased this is now available online "Placebo Effects Are Small on Average in the 7.5% CO2 Inhalational Model of Generalised Anxiety" academic.oup.com/ijnp/advance... 🧵👇

Excited to announce I am joining the #ECNP Early Career Academy! Looking forward to working with everyone else in the academy on applied #neuroskyence

How to define treatment resistance in anxiety disorders? Our Delphi method-based consensus is out now in World Psychiatry. Led by Katharina Domschke and David Baldwin via the ECNP Anxiety Disorders Research Network www.ncbi.nlm.nih.gov/pmc/articles...

"...this requires people to overcome outdated misconceptions of librarianship...Information science is a feminized field, & archivists are ... underpaid & perceived as ... support staff, not co-creators in the knowledge-production process... archives today maintain vast amounts of digital data. "

Humbled to receive this commendation for academic research by the Royal College of Psychiatrists today. Thanks to friends and collaborators who have supported me on this journey so far!

Our review of the emerging evidence for a role of the orexin system in #anxiety disorders is out now #OpenAccess in ECNP journal Neuroscience Applied. Could it be a novel treatment target? With Harry Fagan, Katharina Domschke and David Baldwin www.sciencedirect.com/science/arti...

I’m delighted to be able to share that I have started as an NIHR Academic Clinical Lecturer in General Adult Psychiatry at University of Southampton! Looking forward to working with colleagues on understanding placebo effects and development and maintenance of anxiety disorders